The objective of this Phase 1b investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to...
The purpose of this study is to evaluate the clinical efficacy, safety and pharmacokinetics (PK) of 2 fixed doses of...
The purpose of this study is to assess the efficacy, safety, tolerability and pharmacokinetics (PK) of flexible doses of tavapadon...
It is hoped that TAK-071 will help people with Parkinson's disease to walk with better balance. The main aim of...
The primary objective of this study is to evaluate the safety and tolerability of single and multiple doses of BIIB094...
This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.
This study evaluates the safety and tolerability of CDNF in patients with Parkinson's disease, when dosed directly into the brain...
This study is an extension to the HP-CD-CL-2002 clinical study. It evaluates the long-term safety and tolerability of CDNF in...
The purpose of this study is to evaluate how safinamide, rasagiline and other SoC drugs are associated with the quality...
The objective of this study is to evaluate the performance of novel DBS programming methods compared to traditional programming methods.
The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available...
English (USA)